Zhu Y - Search Results

1

Fibroblast growth factor 15 deficiency impairs liver regeneration in mice.

Kong B, Huang J, Zhu Y, Li G, Williams J, Shen S, Aleksunes LM, Richardson JR, Apte U, Rudnick DA, Guo GL. Kong B, et al. Among authors: zhu y. Am J Physiol Gastrointest Liver Physiol. 2014 May 15;306(10):G893-902. doi: 10.1152/ajpgi.00337.2013. Epub 2014 Apr 3. Am J Physiol Gastrointest Liver Physiol. 2014. PMID: 24699334 Free PMC article.

2

Small heterodimer partner overexpression partially protects against liver tumor development in farnesoid X receptor knockout mice.

Li G, Kong B, Zhu Y, Zhan L, Williams JA, Tawfik O, Kassel KM, Luyendyk JP, Wang L, Guo GL. Li G, et al. Among authors: zhu y. Toxicol Appl Pharmacol. 2013 Oct 15;272(2):299-305. doi: 10.1016/j.taap.2013.06.016. Epub 2013 Jun 26. Toxicol Appl Pharmacol. 2013. PMID: 23811326 Free PMC article.

3

Mechanisms of STAT3 activation in the liver of FXR knockout mice.

Li G, Zhu Y, Tawfik O, Kong B, Williams JA, Zhan L, Kassel KM, Luyendyk JP, Wang L, Guo GL. Li G, et al. Among authors: zhu y. Am J Physiol Gastrointest Liver Physiol. 2013 Dec;305(11):G829-37. doi: 10.1152/ajpgi.00155.2013. Epub 2013 Oct 3. Am J Physiol Gastrointest Liver Physiol. 2013. PMID: 24091600 Free PMC article.

4

Mice with hepatocyte-specific FXR deficiency are resistant to spontaneous but susceptible to cholic acid-induced hepatocarcinogenesis.

Kong B, Zhu Y, Li G, Williams JA, Buckley K, Tawfik O, Luyendyk JP, Guo GL. Kong B, et al. Among authors: zhu y. Am J Physiol Gastrointest Liver Physiol. 2016 Mar 1;310(5):G295-302. doi: 10.1152/ajpgi.00134.2015. Epub 2016 Jan 7. Am J Physiol Gastrointest Liver Physiol. 2016. PMID: 26744468 Free PMC article.

5

Fibroblast growth factor 15 deficiency increases susceptibility but does not improve repair to acetaminophen-induced liver injury in mice.

Huang M, Williams J, Kong B, Zhu Y, Li G, Zhu Z, Guo GL. Huang M, et al. Among authors: zhu y, zhu z. Dig Liver Dis. 2018 Feb;50(2):175-180. doi: 10.1016/j.dld.2017.08.023. Epub 2017 Aug 12. Dig Liver Dis. 2018. PMID: 28867475

6

Tissue-specific function of farnesoid X receptor in liver and intestine.

Zhu Y, Li F, Guo GL. Zhu Y, et al. Pharmacol Res. 2011 Apr;63(4):259-65. doi: 10.1016/j.phrs.2010.12.018. Epub 2011 Jan 4. Pharmacol Res. 2011. PMID: 21211565 Free PMC article. Review.

7

Modulation of farnesoid X receptor results in post-translational modification of poly (ADP-ribose) polymerase 1 in the liver.

Zhu Y, Li G, Dong Y, Zhou HH, Kong B, Aleksunes LM, Richardson JR, Li F, Guo GL. Zhu Y, et al. Toxicol Appl Pharmacol. 2013 Jan 15;266(2):260-6. doi: 10.1016/j.taap.2012.11.012. Epub 2012 Nov 23. Toxicol Appl Pharmacol. 2013. PMID: 23178280 Free PMC article.

8

Fatty liver diseases, bile acids, and FXR.

Zhu Y, Liu H, Zhang M, Guo GL. Zhu Y, et al. Acta Pharm Sin B. 2016 Sep;6(5):409-412. doi: 10.1016/j.apsb.2016.07.008. Epub 2016 Aug 4. Acta Pharm Sin B. 2016. PMID: 27709009 Free PMC article. Review.

9

Association of triglyceride glucose-body mass index and left ventricular hypertrophy in patients with IgA nephropathy: a retrospective study.

Jv M, Zhang J, Han Y, Yang A, Zhu Y. Jv M, et al. Among authors: zhu y. Eur J Med Res. 2024 Dec 26;29(1):627. doi: 10.1186/s40001-024-02234-3. Eur J Med Res. 2024. PMID: 39726054

10

The efficacy and safety of topical combined with intravenous administration of tranexamic acid in spine surgery: a systematic review and meta-analysis.

Xie C, Ren Y, Chen X, Zhu Y, Jiang J, Lu B, Luo H. Xie C, et al. Among authors: zhu y. BMC Musculoskelet Disord. 2024 Dec 27;25(1):1074. doi: 10.1186/s12891-024-08191-6. BMC Musculoskelet Disord. 2024. PMID: 39725950

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54,759 results

Search Page

Filters